Hindustan Bio Science Ltd, originally incorporated as a public limited company in 1991, is a diversified entity operating in the pharmaceutical and biotechnology sectors. Initially focused on sourcing bulk drugs and intermediates, the company transitioned from cement manufacturing to biotechnology and pharmaceuticals due to industry changes. In 2001, it briefly ventured into software, adopting the name Hindustan Softel Ltd before reverting to Hindustan Bio Science Ltd. A significant development was the 2004 acquisition of Venkar Chemicals Ltd, establishing it as a wholly-owned subsidiary.
The company boasts state-of-the-art manufacturing facilities for a variety of pharmaceutical products, including injectables, syrups, drops, and tablets, approved by multiple regulatory bodies. In 2007, it launched 'EPOVIN,' a nephrology product, after receiving approval from the Drugs Controller General of India. Hindustan Bio Science Ltd is recognized globally by healthcare professionals for its high-quality finished dosage forms.
